MODEL RELEASED. Preparation of Moroctocog alfa (trade name ReFacto), a factor VIII (FVIII) blood clotting agent for intravenous injection in a haemophiliac patient. The concentrated preparation is reconstituted before injection. Haemophilia is a hereditary disorder in which the blood clots very slowly, due to a deficiency in one of the blood coagulation factors. FVIII, also known as anti-haemophilic factor (AHF), is an essential blood clotting agent in humans. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5173 px × 3449 px |
Modell-Rechte: | vorhanden |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|